UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
M.D.C. HOLDINGS, INC.
(Name of Issuer)
Common Stock, $0.01 Per Share
(Title of Class of Securities)
552676108
(CUSIP Number)
David D. Mandarich, 3600 S. Yosemite St., Suite 900, Denver, CO 80237
(303) 773-1100
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 9, 2003
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1 (e), 13d-1(f) or 13d-1(g), check the following
box [ ].
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4
SCHEDULE 13D
---------------------------- -----------------------
CUSIP No. 552676108 Page 2 of 4 Pages
---------------------------- -----------------------
===============================================================================
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
David D. Mandarich
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
Not Applicable (b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2 (e) [ ]
Not Applicable
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
-------------------------------------------------------------------------------
7 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SOLE VOTING POWER
2,228,402
-------------------------------------------------------------------------------
8 SHARED VOTING POWER
0
-------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
2,228,402
-------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,228,402
-------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
Not Applicable
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY THE AMOUNT IN ROW (11)
8.22 %
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------------------
------------------------------ -----------------------
CUSIP NO. 552676108 Page 3 of 4 Pages
------------------------------ -----------------------
AMENDMENT
NO. 8
TO THE
SCHEDULE 13D
The Reporting Person, David D. Mandarich, hereby amends his Schedule
13D relating to Common Stock, par value $0.01, of M.D.C. Holdings, Inc.
Item 2. Identity and Background
(b) The Reporting Person's business address is: 3600 South
Yosemite Street, Suite 900, Denver, CO 80237.
(c) The Reporting Person's present principal employment is as
President, Chief Operating Officer and Director of M.D.C. Holdings, Inc.,
3600 South Yosemite Street, Suite 900, Denver, CO 80237.
Item 5. Interest in Securities of the Issuer
(a)-(b) As of the close of business on January 9, 2003, the
Reporting Person, by virtue of the language of Rule 13d-3, may be deemed to own
beneficially and to hold the sole power to vote and dispose of, in the aggregate
the number and percentage of the Issuer's Common Stock set forth below opposite
his name (based upon the number of shares of the Issuer's Common Stock that were
reported to be outstanding in the Issuer's Form 10-Q as of September 30, 2002).
===============================================================================
Name Shares of Common Stock Percentage
-------------------------------------------------------------------------------
David D. Mandarich (1)(2) 2,228,402 8.22 %
-------------------------------------------------------------------------------
(1) Includes 1,200 shares of Common Stock owned by the Reporting Person's
minor children and 1,530 shares of Common Stock held in the Reporting
Person's 401(k) Plan account.
(2) Includes 451,822 shares of Common Stock that the Reporting Person
has the right to acquire within 60 days of January 9, 2003.
------------------------------ -----------------------
CUSIP NO. 552676108 Page 4 of 4 Pages
------------------------------ -----------------------
(c) The following table sets forth the transactions by the
Reporting Person listed in Item 5(a) during the past sixty days.
===============================================================================
Trade Price Per
Date Share ($) David D. Mandarich
-------------------------------------------------------------------------------
12/09/02 n/a 4,800(1)
01/09/03 n/a 46,494(2)
-------------------------------------------------------------------------------
(1) Reflects gifts of common stock, including gifts of 1,200 shares to the
Reporting Person's minor children.
(2) Reflects the grant of 46,494 shares on January 9, 2003 in payment of a
portion of the Reporting Person's 2002 bonus compensation pursuant to the M.D.C.
Holdings, Inc. Executive Officer Performance-Based Compensation Plan.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: January 10, 2003
By: /s/ David D. Mandarich
--------------------------
David D. Mandarich
President, Chief Operating
Officer and Director